What is PHIO's dilution risk score?

PHIO has a latest available DilutionScore record of 36/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for PHIO, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for PHIO?

DilutionWatch tracks 25 SEC filing types for PHIO including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect PHIO shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For PHIO, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for PHIO tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for PHIO. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

PHIO Dilution Risk Score: 36/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

10

📊 Float Risk

10

⚠️ Warrant Exposure

40

🔄 Convertible Debt

15

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 15%

🔄 Reverse Split model est. 30%

• 50-day avg $1.19 approaching $1 threshold

🔔 Track PHIO — Get forecast alerts →

Market Data

Market Cap$12.90M

Shares Outstanding11.62M

Float11.55M

Cash$21.00M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↑ 108.2% shares (2026Q1 vs prior)

25 institutional holders · 760.6K shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 159.7K shares

#2 GEODE CAPITAL MANAGEMENT, LLC 147.3K shares

#3 JANE STREET GROUP, LLC 119.2K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest287.3K

Days to Cover1.0

% of Float2.5%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2021-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual PHIO Dilution Snapshot

Phio Pharmaceuticals Corp. (PHIO) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for PHIO: xbrl on 2026-06-30; xbrl on 2021-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.